This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Lawrence Sellin - Innovator in Pharmaceutical Compounds
Introduction
Lawrence Sellin is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic lactam compounds. His work is aimed at addressing critical health issues, including congestive heart failure.
Latest Patents
Lawrence Sellin holds a patent for a compound described as heterocyclic lactam compounds. This compound is effective in the treatment of congestive heart failure and is characterized by a complex formula involving various chemical groups and configurations. The patent details the specific structural components and their potential therapeutic applications.
Career Highlights
Sellin is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on innovative solutions that enhance patient care and treatment outcomes. With a patent portfolio that includes one significant patent, he continues to contribute to advancements in medical science.
Collaborations
Throughout his career, Lawrence Sellin has collaborated with esteemed colleagues, including Irma O Ojala and Erkki J Honkanen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Lawrence Sellin's contributions to pharmaceutical innovations, particularly in the area of heterocyclic lactam compounds, highlight his commitment to improving healthcare. His work continues to influence the field and offers hope for effective treatments for serious medical conditions.